Skip to main content

ADVERTISEMENT

IAGS (International Andreas Gruentzig Society) Proceedings

IAGS (International Andreas Gruentzig Society) Proceedings
08/01/2008
Moderator: Mike Cowley Panelists: Scott Byrd and Philip Reid (Eli Lilly and Company); Renato DeRita (Centocor); John Spencer (Genentech)
Moderator: Mike Cowley Panelists: Sco...
Philip Reid (Eli Lilly & Company): Speaking as a cardiologist, not as a neurologist, I find that the challenge with the trial that Renato has just described is to demonstrate the efficacy of abciximab in acute nonhemorrhagic stroke patients....
Philip Reid (Eli Lilly & Company): Speaking as a cardiologist, not as a neurologist, I find that the challenge with the trial that Renato has just described is to demonstrate the efficacy of abciximab in acute nonhemorrhagic stroke patients....
Philip Reid (Eli Lilly &...
08/01/2008
Journal of Invasive Cardiology
IAGS (International Andreas Gruentzig Society) Proceedings
08/01/2008
L. Nelson Hopkins, MD
L. Nelson Hopkins, MD
When I think about the way we treat carotid disease, I see a great example of multiple specialties that are not working together. Everybody has something to offer the specialty of carotid stenting, and everybody, in my view, needs to possess...
When I think about the way we treat carotid disease, I see a great example of multiple specialties that are not working together. Everybody has something to offer the specialty of carotid stenting, and everybody, in my view, needs to possess...
When I think about the way we...
08/01/2008
Journal of Invasive Cardiology
IAGS (International Andreas Gruentzig Society) Proceedings
08/01/2008
L. Nelson (Nick) Hopkins, MD
L. Nelson (Nick) Hopkins, MD
David Holmes really set the stage with his discussion, but let me also summarize what stroke means today. After suffering a major stroke, one-third of patients will recover, one-third will die, and one-third will be wrecked; it’s the latter...
David Holmes really set the stage with his discussion, but let me also summarize what stroke means today. After suffering a major stroke, one-third of patients will recover, one-third will die, and one-third will be wrecked; it’s the latter...
David Holmes really set the...
08/01/2008
Journal of Invasive Cardiology
IAGS (International Andreas Gruentzig Society) Proceedings
08/01/2008
David Holmes, MD, Moderator
David Holmes, MD, Moderator
We’re going to move on to the second session entitled: Contemporary Prevention, Management and Treatment of Stroke — Who Will Treat Acute Stroke in 2010 and How Will It Be Treated?The data on this first slide (Figure 1) show the magnitude of...
We’re going to move on to the second session entitled: Contemporary Prevention, Management and Treatment of Stroke — Who Will Treat Acute Stroke in 2010 and How Will It Be Treated?The data on this first slide (Figure 1) show the magnitude of...
We’re going to move on to the...
08/01/2008
Journal of Invasive Cardiology
IAGS (International Andreas Gruentzig Society) Proceedings
08/01/2008
Frank Criado, MD
Frank Criado, MD
I’m going to give you a perspective on where we see the current state of carotid artery stenting from the regulatory and reimbursement perspectives, and perhaps a bit of technical unmet needs and future prospects. Obviously, this is going to...
I’m going to give you a perspective on where we see the current state of carotid artery stenting from the regulatory and reimbursement perspectives, and perhaps a bit of technical unmet needs and future prospects. Obviously, this is going to...
I’m going to give you a...
08/01/2008
Journal of Invasive Cardiology
IAGS (International Andreas Gruentzig Society) Proceedings
08/01/2008
Renato DeRita, MS
Renato DeRita, MS
First of all, I would like to thank the organizers of this meeting, particularly Dr. Michael Cowley, who asked me to attend. It’s an honor to be here. As a biochemist who has spent most of his life with his head in the “cell-culture”...
First of all, I would like to thank the organizers of this meeting, particularly Dr. Michael Cowley, who asked me to attend. It’s an honor to be here. As a biochemist who has spent most of his life with his head in the “cell-culture”...
First of all, I would like to...
08/01/2008
Journal of Invasive Cardiology
IAGS (International Andreas Gruentzig Society) Proceedings
08/01/2008
Sigrid Nikol, MD, William W. O’Neill, MD, Joseph Babb, MD, Jorge Belardi, MD, Timothy Henry, MD, Robert Simari, MD
Sigrid Nikol, MD, William W. O’Neil...
Prof. Dr. Sigrid Nikol MD: I welcome you to this session, New Developments in Gene Therapy and Stem Cells for Angiogenesis in the Treatment of Myocardial Infarction. Initial developments of regenerative therapies were mainly angiogenesis...
Prof. Dr. Sigrid Nikol MD: I welcome you to this session, New Developments in Gene Therapy and Stem Cells for Angiogenesis in the Treatment of Myocardial Infarction. Initial developments of regenerative therapies were mainly angiogenesis...
Prof. Dr. Sigrid Nikol MD: I...
08/01/2008
Journal of Invasive Cardiology
IAGS (International Andreas Gruentzig Society) Proceedings
08/01/2008
Robert Simari, MD
Robert Simari, MD
Robert Simari, MD: I appreciate this opportunity to present some general insights into the fields of gene and cell therapy, both from a perspective as an experimental biologist, as a clinician as well as from a regulatory perspective to see...
Robert Simari, MD: I appreciate this opportunity to present some general insights into the fields of gene and cell therapy, both from a perspective as an experimental biologist, as a clinician as well as from a regulatory perspective to see...
Robert Simari, MD: I appreciate...
08/01/2008
Journal of Invasive Cardiology
IAGS (International Andreas Gruentzig Society) Proceedings
08/01/2008
Alfred Bollinger, MD and Maria Schlumpf, PA
Alfred Bollinger, MD and Maria Schlum...
When German-born Andreas Roland Grüntzig arrived in 1969 in Zurich, Switzerland, and joined the Angiology Division of the University Hospital, founded some years before, he stated: “I have dedicated my life to the vascular diseases”.1 First,...
When German-born Andreas Roland Grüntzig arrived in 1969 in Zurich, Switzerland, and joined the Angiology Division of the University Hospital, founded some years before, he stated: “I have dedicated my life to the vascular diseases”.1 First,...
When German-born Andreas Roland...
08/01/2008
Journal of Invasive Cardiology
IAGS (International Andreas Gruentzig Society) Proceedings
08/01/2008
Larry S. Dean, MD
Larry S. Dean, MD
Since the discovery of X-rays in 1895, there has been continuous development, first of imaging techniques, but over the last several decades, of therapeutics, to address the number-one killer of individuals in the industrialized world….heart...
Since the discovery of X-rays in 1895, there has been continuous development, first of imaging techniques, but over the last several decades, of therapeutics, to address the number-one killer of individuals in the industrialized world….heart...
Since the discovery of X-rays in...
08/01/2008
Journal of Invasive Cardiology